A Study of Acute Kidney Injury in Care Transitions

Not Applicable

Completed

• Conditions: Acute Kidney Injury
• Interventions: Behavioral: AKI in Care Transitions (ACT) program

• Registration Number: NCT05184894
• Lead Sponsor: Mayo Clinic

Brief Summary

This research is being done to develop materials and processes that will help facilitate education and kidney care coordination for AKI survivors.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-12-22
• Study First Submitted QC: 2021-12-22
• Study First Posted: 2022-01-11
• Study Start: 2022-01-17
• Primary Completion: 2023-10-31
• Study Completion: 2023-10-31
• Results First Submitted: 2024-09-12
• Results First Submitted QC: 2024-10-10
• Results First Posted: 2024-11-25
• Status Verified: 2024-12
• Last Update Submitted: 2024-12-03
• Last Update Posted: 2024-12-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Participants will be recruited from those identified by a developed electronic health record list of patients with stage III AKI (severe) during a hospitalization based on serum creatinine rise or urine output decline from Olmsted County.

Read More

Exclusion Criteria

• Dementia.
• Non-English speaking.
• Expected to be dismissed to a skilled nursing facility or hospice at discharge.
• Expected to need dialysis at discharge.
• Primary Care Transitions Program enrollment.
• Transplant recipients within 100 days of transplant.
• Can only have one time enrollment.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
AKI in Care Transitions (ACT) Group	AKI in Care Transitions (ACT) program	Subjects diagnosed with Acute Kidney Injury (AKI) during their hospital stay will participate in the ACT program which provides standardized education and assists with coordination of follow up care after hospital stay.

Primary Outcome Measures

Name	Time	Method
Number of Subjects to Complete the ACT Program	30 days after hospitalization	Total number of subjects to complete the full ACT program intervention

Trial Locations

Locations (1)

Mayo Clinic in Rochester; 🇺🇸 Rochester, Minnesota, United States